Results 41 to 50 of about 11,553 (254)

Impella RP

JACC: Case Reports, 2019
Due to the scarcity of data, Impella RP is not approved for acute right ventricular failure caused by massive pulmonary embolism. We describe here the successful use of Impella RP in acute right ventricular failure caused by massive pulmonary embolism to highlight its promising outcome in such an indication. (Level of Difficulty: Advanced.)
Ahmed Taha, Assad Mohammedzein, John Kimbugwe, Kade Carthel, David Brabham   +4 more
openaire   +2 more sources

Impella flow pump reinsertion after axillary graft thrombectomy: Technical points in replacing axillary Impella [PDF]

SAGE Open Medical Case Reports, 2021
Axillary Impella devices are increasingly employed for long-term support of patients with systolic heart failure and shock. Axillary access allows for awake support and ambulation, which carries an inherent risk of disconnection or malposition. We report a series of two cases where device replacement due to dysfunction and malposition can be completed
Osama Haddad, Samuel Jacob, Ryan L Ung, Rohan M Goswami, Parag C Patel, Si M Pham, Basar Sareyyupoglu   +6 more
openaire   +3 more sources

Rotary mechanical circulatory support systems

, 2017
A detailed survey of the current trends and recent advances in rotary mechanical circulatory support systems is presented in this paper. Rather than clinical reports, the focus is on technological aspects of these rehabilitating devices as a reference ...
Bonnell, Mark, Elahinia, Mohammad, Gupta, Rajesh, Hosseinipour, Milad   +3 more
core   +1 more source

Transplantation in end-stage pulmonary hypertension (Third International Right Heart Failure Summit, part 3) [PDF]

, 2015
The Third International Right Heart Summit was organized for the purpose of bringing an interdisciplinary group of expert physician-scientists together to promote dialogue involving emerging concepts in the unique pathophysiology, clinical manifestation,
Lala, Anuradha
core   +1 more source

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory ...
Yuichi Saito, Kazuya Tateishi, Koichi Toda, Goro Matsumiya, Yoshio Kobayashi   +4 more
doaj   +1 more source

Percutaneous Impella Mechanical Circulatory Support Delivery Using Intravascular Lithotripsy

JACC: Case Reports, 2020
Intravascular lithotripsy (IVL) may be useful to deliver Impella devices in patients with peripheral arterial disease. Twelve patients were treated with peripheral IVL prior to Impella insertion.
Robert F. Riley, MD, MS, Brian Kolski, MD, Chandanreddy M. Devireddy, MD, Amir Kaki, MD, Antonious Attallah, Mitul B. Kadakia, MD, Carlo Di Mario, MD, Dean Kereiakes, MD   +7 more
doaj   +1 more source

Fulminantne müokardiit. Haigusjuht ja kirjanduse ülevaade [PDF]

, 2018
Müokardiit on heterogeenne haigus nii etioloogia kui ka kliinilise kulu poolest. Haiguse aluseks on põletikuline südamelihase kahjustus, mis kulgeb ägeda, enamasti taaspöörduva sündroomina.
Altmets, Mait, Kütt, Marge, Leismann, Tiina, Lotman, Eno-Martin, Reinmets, Julia, Rätsep, Indrek   +5 more
core   +2 more sources

Short- and long-term outcomes of Impella-protected, high-risk, elective PCI in patients with multivessel coronary disease and low ejection fraction — Polish Impella Registry

Cardiology Journal
BACKGROUND: The Impella percutaneous mechanical circulatory support device provides improved support in treating patients with high-risk percutaneous coronary interventions (HR-PCI) or in cardiogenic shock.
Wojciech J. Skorupski, Arkadiusz Pietrasik, Aleksandra Gąsecka, Jerzy Sacha, Tomasz Pawłowski, Gabriel Bielawski, Wojciech Balak, Adam Sukiennik, Paulina Burzyńska, Adam Witkowski, Mateusz Warniełło, Łukasz Rzeszutko, Stanisław Bartuś, Artur Pawlik, Mateusz Kaczyński, Robert Gil, Wiktor Kuliczkowski, Krzysztof Reczuch, Marcin Protasiewicz, Jacek Legutko, Paweł Kleczyński, Piotr Wańczura, Sebastian Gurba, Anna Kochanowska, Michał Łomiak, Maciej Krajsman, Włodzimierz Skorupski, Maciej Zarębiński, Piotr Pawluczuk, Szymon Włodarczak, Adrian Włodarczak, Krzysztof Ściborski, Artur Telichowski, Mieszko Pluciński, Jarosław Hiczkiewicz, Karolina Konsek, Michał Hawranek, Mariusz Gąsior, Jan Peruga, Marcin Fiutowski, Robert Romanek, Piotr Kasprzyk, Dariusz Ciećwierz, Andrzej Ochała, Wojciech Wojakowski, Janusz Kochman, Maciej Lesiak, Marek Grygier   +47 more
doaj   +1 more source

Impella Retrieval: Redux

JACC: Cardiovascular Interventions, 2017
We were pleased to read “First Experience With Successful Percutaneous Retrieval of Retained-Fractured Impella Device” in JACC: Cardiovascular Interventions [(1)][1]. Because temporary mechanical circulatory support devices are used with increasing frequency, we are likely to ...
openaire   +2 more sources

A Review of the Impella Devices

Interventional Cardiology: Reviews, Research, Resources, 2022
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogenic shock or to support high-risk percutaneous coronary intervention (HRPCI) has grown over the past decade. There is currently no consensus on best practice regarding its use in these two distinct indications.
Rami Zein, Chirdeep Patel, Adrian Mercado-Alamo, Theodore Schreiber, Amir Kaki   +4 more
openaire   +3 more sources